CRO

TPG buys Actavis' contracting firm; Novella staffed up since Quintiles buyout;

> TPG closed its acquisition of Aptalis, Actavis' ($ACT) in-house R&D outsourcing company, rechristening it Adare Pharma. News

> IPCA Laboratories' Onyx Scientific is expanding its API manufacturing operation in the U.K. More

> Novella Clinical has added about 90 employees since Quintiles ($Q) bought it for $147 million in 2013. Item